PRESS RELEASE DETERA Therapeutics Wins the Ipsen Golden Ticket 2025 A strategic recognition of the biotech’s potential by a leading pharmaceutical group Paris, October 15th 2025 — DETERA Therapeutics, a biotechnology company specializing in disruptive …